RETRACTED: Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway (Retracted Article)

被引:37
|
作者
Pan, Bao-Long [1 ]
Tong, Zong-Wu [2 ]
Wu, Ling [3 ]
Pan, Li [1 ]
Li, Jun-E [1 ]
Huang, You-Guang [4 ]
Li, Shu-De [5 ]
Du, Shi-Xun [1 ]
Li, Xu-Dong [1 ]
机构
[1] Peoples Hosp Yuxi City, Dept Lab, Yuxi, Peoples R China
[2] Peoples Hosp Yuxi City, Dept Nephrol, Yuxi, Peoples R China
[3] Cent Blood Stn Yuxi City, Dept Qual Control, Yuxi, Peoples R China
[4] Kunming Med Univ, Affiliated Hosp 3, Tumor Inst Yunnan Prov, Tumor Markers Res Ctr, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China
[5] Kunming Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Kunming, Yunnan, Peoples R China
关键词
MicroRNA-206; ANXA2; AKT signaling pathway; Osteosarcoma; Proliferation; Invasion; PROGRESSION; CANCER; PATHOGENESIS; EXPRESSION; PROGNOSIS; ROLES;
D O I
10.1159/000487567
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: This study aimed to investigate the mechanism by which microRNA-206 (miR-20() affects the proliferation, apoptosis, migration and invasion of osteosarcoma (OS) cells by targeting ANXA2 via the AKT signaling pathway. Methods: A total of 132 OS tissues and 120 osteochondroma tissues were examined in this study. The targeting relationship between miR-206 and ANXA2 was verified with a dual-luciferase reporter assay. The miR-206 expression and ANXA2, AKT, PARP, FASN, Survivin, Bax, Mcl-1 and Bcl-1 mRNA and protein expression in the above two groups were examined by qRT-PCR and western blotting. The cultured OS cells were divided into 6 groups: a blank group, negative control (NC) group, miR-206 mimic group, miR-206 inhibitor group, si-ANXA2 group and miR-206 inhibitor + si ANXA2 group. Cell cycle and apoptosis were assessed by flow cytometry, cell migration was examined with a wound-healing assay, and cell invasion was assessed with a Transwell assay. Pearson correlation analysis was used to determine the correlation between ANXA2 mRNA expression and miR-206 expression in OS. Results: OS tissues exhibited increased mRNA and protein expression of ANXA2, AKT, PARP, FASN, Survivin, Mcl-1 and Bcl-2; decreased miR-206 expression; and decreased Bax mRNA and protein expression. ANXA2 mRNA expression was strongly negatively correlated with miR-206 expression in OS. ANXA2 was found to be a miR-206 target gene. In the miR-206 mimic group and the si-ANXA2 group, the mRNA and protein expression of ANXA2, AKT, PARP, FASN, Survivin, Mcl-1 and Bcl-1 decreased markedly, cell proliferation was inhibited, apoptosis was promoted, higher cell growth in G1 phase and decreased growth in S phase was detected, and decreased cell migration and invasion were observed compared with those in the blank group. Conclusion: The current results demonstrate that miR-206 overexpression inhibits OS cell proliferation, migration and invasion and promotes apoptosis through targeting ANXA2 by blocking the AKT signaling pathway. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1410 / 1422
页数:13
相关论文
共 50 条
  • [21] RETRACTED: LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway (Retracted Article)
    Wang, Z-X
    Xu, Z-N
    Sun, H-B
    Wang, Y.
    Han, Z-F
    Yu, Y.
    Han, X-L
    Yin, Y-Y
    Xu, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (01) : 222 - 229
  • [22] RETRACTED: MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1 (Retracted Article)
    Chen, H-S
    Lu, A-Q
    Yang, P-Y
    Liang, J.
    Wei, Y.
    Shang, Y-W
    Li, Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (15) : 6621 - 6628
  • [23] RETRACTED: miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2 (Retracted Article)
    He, Qian-Yun
    Wang, Guang-Chao
    Zhang, Hao
    Tong, Da-Ke
    Ding, Chen
    Liu, Kang
    Ji, Fang
    Zhu, Xiongbai
    Yang, Shengwu
    DNA AND CELL BIOLOGY, 2016, 35 (09) : 506 - 520
  • [24] RETRACTED: Effects of the Wnt/β-Catenin Signaling Pathway on Proliferation and Apoptosis of Gastric Cancer Cells (Retracted Article)
    Chen, Jia
    Wang, Xingyu
    Zhang, Jianlin
    Chang, Jiawei
    Han, Chuanjun
    Xu, Zhouwei
    Yu, Hongzhu
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [25] RETRACTED: Effects of microRNA-21 targeting PITX2 on proliferation and apoptosis of pituitary tumor cells (Retracted Article)
    Cui, M.
    Zhang, M.
    Liu, H-F
    Wang, J-P
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (13) : 2995 - 3004
  • [26] RETRACTED: Anhuienoside C inhibits human ovarian cancer cell growth by inducing apoptosis, suppression of cell migration and invasion, and targeting PI3K/AKT/mTOR signaling pathway (Retracted Article)
    Zhu, Yan
    Yang, Lijuan
    Chen, Youguo
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2022, 477 (07) : 1887 - 1892
  • [27] RETRACTED: circSMARCA5 Promoted Osteosarcoma Cell Proliferation, Adhesion, Migration, and Invasion through a Competing Endogenous RNA Network (Retracted Article)
    Zhang, Hepeng
    Meng, Fanyu
    Dong, Shuaicheng
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [28] RETRACTED: MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2 (Retracted Article)
    Xie, Xi
    Li, Yu-Sheng
    Xiao, Wen-Feng
    Deng, Zhen-Han
    He, Hong-Bo
    Liu, Qing
    Luo, Wei
    BIOSCIENCE REPORTS, 2017, 37
  • [29] RETRACTED: MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway (Retracted Article)
    Xu, M.
    Tian, G-L
    Hao, C-C
    Shi, M.
    Zha, D-J
    Liang, K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (12) : 5215 - 5222
  • [30] RETRACTED: MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1 (Retracted Article)
    Liu, Jian
    Chen, Bohua
    Yue, Bin
    Yang, Junde
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 4135 - 4141